NL7016766A - - Google Patents
Info
- Publication number
- NL7016766A NL7016766A NL7016766A NL7016766A NL7016766A NL 7016766 A NL7016766 A NL 7016766A NL 7016766 A NL7016766 A NL 7016766A NL 7016766 A NL7016766 A NL 7016766A NL 7016766 A NL7016766 A NL 7016766A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87744369A | 1969-11-17 | 1969-11-17 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7016766A true NL7016766A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1971-05-19 |
| NL171589B NL171589B (nl) | 1982-11-16 |
| NL171589C NL171589C (nl) | 1983-04-18 |
Family
ID=25369972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7016766,A NL171589C (nl) | 1969-11-17 | 1970-11-16 | Werkwijze ter bereiding van een farmaceutisch preparaat met werkzaamheid tegen virusinfecties, alsmede werkwijze ter bereiding van een 9-(beta-d-arabinofuranosyl)purine. |
Country Status (26)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4081534A (en) * | 1973-09-11 | 1978-03-28 | Burroughs Wellcome Co. | Amino purine nucleosides as autoimmune suppressant agents |
| GB1562899A (en) * | 1975-06-17 | 1980-03-19 | Wellcome Found | Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof |
| US4210745A (en) * | 1978-01-04 | 1980-07-01 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine |
| DE3319282A1 (de) * | 1983-05-27 | 1984-11-29 | Gödecke AG, 1000 Berlin | Verwendung von adenosin bei der behandlung von herpes |
| GB8712745D0 (en) * | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
| AU626296B2 (en) * | 1988-03-16 | 1992-07-30 | Scripps Clinic And Research Foundation | Substituted adenine derivatives useful as therapeutic agents |
| US5292725A (en) * | 1988-08-25 | 1994-03-08 | Prendergast Patrick T | Administering particular compounds against various parasites, mycoplasmas, other indications and other infections |
| IE882585L (en) * | 1988-08-25 | 1990-02-25 | Prendergast Patrick T | Viral treatment system |
| US5681941A (en) * | 1990-01-11 | 1997-10-28 | Isis Pharmaceuticals, Inc. | Substituted purines and oligonucleotide cross-linking |
| US5308837A (en) * | 1990-08-22 | 1994-05-03 | Merrell Dow Pharmaceuticals Inc. | 5'-amine substituted adenosine analogs as immunosuppressants |
| US6338963B1 (en) | 1994-07-25 | 2002-01-15 | Neotherapeutics, Inc. | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| US6232463B1 (en) | 1997-10-09 | 2001-05-15 | Isis Pharmaceuticals, Inc. | Substituted purines and oligonucleotide cross-linking |
| US6303617B1 (en) | 1998-05-04 | 2001-10-16 | Neotherapeutics, Inc. | Serotonin-like 9-substituted hypoxanthine and methods of use |
| US6288069B1 (en) | 1999-11-16 | 2001-09-11 | Neotherapeutics, Inc. | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| US6407237B1 (en) | 2001-02-21 | 2002-06-18 | Neotherapeutics, Inc. | Crystal forms of 9-substituted hypoxanthine derivatives |
| US6849735B1 (en) | 2000-06-23 | 2005-02-01 | Merck Eprova Ag | Methods of synthesis for 9-substituted hypoxanthine derivatives |
| WO2002004448A2 (en) | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| US6759427B2 (en) * | 2001-04-20 | 2004-07-06 | Spectrum Pharmaceuticals, Inc. | Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| US20030055249A1 (en) * | 2001-07-17 | 2003-03-20 | Fick David B. | Synthesis and methods of use of pyrimidine analogues and derivatives |
| CN105237602B (zh) * | 2015-06-25 | 2018-05-18 | 新乡学院 | 一种2-氨基阿糖腺苷的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1070413A (en) * | 1962-11-15 | 1967-06-01 | Sankyo Co | A process for preparing purine and pyrimidine nucleosides |
| US3407191A (en) * | 1966-08-29 | 1968-10-22 | Lilly Co Eli | Adamantoate esters of nucleosides |
| JPH1097965A (ja) * | 1996-09-20 | 1998-04-14 | Sony Corp | 生産管理方法 |
-
0
- BE BE759011D patent/BE759011A/xx not_active IP Right Cessation
-
1969
- 1969-11-17 US US877443A patent/US3666856A/en not_active Expired - Lifetime
- 1969-12-15 BR BR215136/69A patent/BR6915136D0/pt unknown
-
1970
- 1970-11-10 MC MC923A patent/MC869A1/xx unknown
- 1970-11-16 ES ES385590A patent/ES385590A1/es not_active Expired
- 1970-11-16 NO NO04378/70A patent/NO128156B/no unknown
- 1970-11-16 FI FI3069/70A patent/FI54315C/fi active
- 1970-11-16 FR FR7040956A patent/FR2073364B1/fr not_active Expired
- 1970-11-16 ZA ZA707722A patent/ZA707722B/xx unknown
- 1970-11-16 CS CS7000007720A patent/CS181701B2/cs unknown
- 1970-11-16 PL PL1970144449A patent/PL81167B1/pl unknown
- 1970-11-16 AT AT1028370A patent/AT309696B/de not_active IP Right Cessation
- 1970-11-16 GB GB5450270A patent/GB1338905A/en not_active Expired
- 1970-11-16 HU HUWE425A patent/HU163812B/hu unknown
- 1970-11-16 CH CH1431873A patent/CH555833A/xx not_active IP Right Cessation
- 1970-11-16 NL NLAANVRAGE7016766,A patent/NL171589C/xx not_active IP Right Cessation
- 1970-11-16 JP JP10095870A patent/JPS5429520B1/ja active Pending
- 1970-11-16 SE SE7015440A patent/SE385374B/xx unknown
- 1970-11-16 LU LU62071D patent/LU62071A1/xx unknown
- 1970-11-16 IE IE1470/70A patent/IE34737B1/xx unknown
- 1970-11-16 CH CH1694070A patent/CH555344A/xx not_active IP Right Cessation
- 1970-11-16 IL IL35658A patent/IL35658A/en unknown
- 1970-11-16 DK DK581070AA patent/DK128117B/da not_active IP Right Cessation
- 1970-11-16 YU YU2806/70A patent/YU35033B/xx unknown
- 1970-11-16 DE DE2056327A patent/DE2056327C2/de not_active Expired
- 1970-11-16 CA CA098,272A patent/CA967564A/en not_active Expired
- 1970-11-16 GB GB2751373A patent/GB1338906A/en not_active Expired
- 1970-11-17 ZM ZM129/70A patent/ZM12970A1/xx unknown
-
1973
- 1973-04-16 ES ES413787A patent/ES413787A1/es not_active Expired
-
1978
- 1978-08-24 YU YU2019/78A patent/YU35034B/xx unknown
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V1 | Lapsed because of non-payment of the annual fee |